Form 4 for HBIO HARVARD BIOSCIENCE INC
Accepted 2025-08-11 00:00:00 ET · period of report 2025-08-08 · accession 0001104659-25-076302 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-08-11 | 2025-08-08 | HBIO | Duke John D | CEO, Dir | A - Grant | $0.00 | +1.00M | 1.00M | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-08 | A | A | 500,000 | $0.00 | 500,000 | D | — | — | (F1) Represents an award of 500,000 restricted stock units (RSUs) that will vest in three equal installments on August 8, 2026, 2027 and 2028, subject to the terms set forth in an award agreement between the Issuer and the Reporting Person. |
| 2 | Common | Common Stock | 2025-08-08 | A | A | 500,000 | $0.00 | 1,000,000 | D | — | — | (F2) Represents an award of 500,000 RSUs with performance based vesting conditions. These RSUs will vest upon the achievement of a relative total shareholder return of the Issuer's common stock during the period from August 8, 2025 to the earlier of (i) July 30, 2028, and (ii) the date of a change of control, measured relative to the Russell2000 index, subject to the terms set forth in an award agreement between the Issuer and the Reporting Person. The target number of these RSUs that may be earned is reported above; the maximum amount is 150% of the number reported. (F3) Includes the awards described in footnotes (1) and (2) above. |